Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Erickson

Michael Erickson is recorded as CEO at Idexx Laboratories Inc /De (IDXX). Idexx Laboratories Inc /De reported in an 8-K filed January 13, 2026 that Michael Erickson was appointed President and Chief Executive Officer, effective May 12, 2026. Michael Erickson has spoken on 1 earnings call across 1 company, most recently for Idexx Laboratories Inc /De on May 5, 2026.

“This Agreement amends and restates in its entirety the Change in Control Agreement by and between the Company and the Executive dated as of August 2, 2024 and will become effective upon the assumption by Executive of the role of President and Chief Executive Officer, which is currently expected to occur on May 12, 2026 (the "Agreement Date"), subject to the Executive's continued employment with the Company through the Agreement Date.”
Idexx Laboratories Inc /De Form 8-K, filed January 13, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Idexx Laboratories Inc /De

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.